Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Revenue

Harmony Biosciences Holdings had revenue of $239.46M in the quarter ending September 30, 2025, with 28.71% growth. This brings the company's revenue in the last twelve months to $825.94M, up 21.13% year-over-year. In the year 2024, Harmony Biosciences Holdings had annual revenue of $714.73M with 22.80% growth.

• Revenue (ttm): $825.94M
• Revenue Growth: +21.13%
• P/S Ratio: 2.66
• Revenue / Employee: $3,081,881
• Employees: 268
• Market Cap: 2.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	714.73M	132.71M	22.80%
Dec 31, 2023	582.02M	144.17M	32.93%
Dec 31, 2022	437.86M	132.42M	43.35%
Dec 31, 2021	305.44M	145.70M	91.21%
Dec 31, 2020	159.74M	153.75M	2,564.59%